Beijing 302 Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• HIV1 trial
• Liver and biliary tract cancer1 trial
• Liver cirrhosis1 trial
• Primary biliary cholangitis1 trial

Phase

• Phase 1/22 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Beijing 302 Hospital2 trials
• Cell Energy Life Sciences Group Co. LTD1 trial
• Humanity & Health Medical Group Limited1 trial

Running trials

• Not yet recruiting

  Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis

  NCT07795151· Phase 1/2· Beijing 302 Hospital· Source

  Contact: Lei Shi, MD, PhD

• Recruiting

  Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

  NCT05224960· Phase 2· Beijing 302 Hospital· Source

  Contact: Lei Shi, MD, PhD

• Recruiting

  Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

  NCT05939167· Phase 1/2· Cell Energy Life Sciences Group Co. LTD· Source

  Contact: Fu-Sheng Wang, Doctor

• Recruiting

  The Overall Survival of Patients With Unresectable HCC in Real-life

  NCT03612726· Humanity & Health Medical Group Limited· Source

  Contact: Guofeng Chen, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting
• Liver cirrhosis1 recruiting
• Primary biliary cholangitis1 recruiting